PRF Technologies (PRFX) vs Sunshine Biopharma (SBFM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Sunshine Biopharma is the larger company by market cap ($1.8 million vs $1.7 million), about 1.1 times the size. Sunshine Biopharma converts more of its revenue into profit, with a net margin of -16.5% versus -29541.2%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PRFX | SBFM |
|---|---|---|
| Share price | $0.4758 | $2.23 |
| Market cap | $1.66M | $1.84M |
| 1-day change | -23.68% | -5.11% |
| Forward P/E | — | 0.01 |
| EPS (TTM) | $-4.09 | $-620.60 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $17.00K | $36.31M |
| Revenue growth (YoY) | — | +4.11% |
| Net income (latest FY) | $-5.02M | $-5.98M |
| Gross margin | -311.76% | 33.76% |
| Operating margin | -30129.41% | -17.15% |
| Net margin | -29541.18% | -16.46% |
| 52-week high | $7.95 | $464.00 |
| 52-week low | $0.46 | $2.23 |
| Distance from 52-week high | -94.02% | -99.52% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +2411.21% |
| Average volume | 228.55K | 301.48K |
| Shares outstanding | 3.50M | 823.77K |
| Employees | 6 | 50 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Sunshine Biopharma is more profitable, keeping -16.5 cents of every revenue dollar as net income versus -29541.2 cents for PRF Technologies.
About PRF Technologies
PRFX stock →PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia.
Health Care · Biotechnology: Pharmaceutical Preparations · 6 employees
About Sunshine Biopharma
SBFM stock →Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada.
Health Care · Biotechnology: Pharmaceutical Preparations · 50 employees
PRFX vs SBFM FAQ
Which is bigger, PRF Technologies or Sunshine Biopharma?
Sunshine Biopharma (SBFM) is larger, with a market capitalization of $1.84M compared with $1.66M for PRF Technologies (PRFX).
Are PRF Technologies and Sunshine Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.